rdf:type |
|
lifeskim:mentions |
umls-concept:C0031327,
umls-concept:C0036043,
umls-concept:C0205314,
umls-concept:C0679622,
umls-concept:C0681850,
umls-concept:C1550501,
umls-concept:C1556095,
umls-concept:C1706203,
umls-concept:C1742789,
umls-concept:C2349001,
umls-concept:C2697811,
umls-concept:C2923059
|
pubmed:issue |
6
|
pubmed:dateCreated |
2008-5-14
|
pubmed:abstractText |
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: The phosphodiesterase (PDE) type 5 inhibitor is a widely used agent that facilitates penile erection. Udenafil is newly developed as a PDE-5 inhibitor.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/18318773-10073779,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18318773-10219969,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18318773-10853004,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18318773-11289568,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18318773-11879254,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18318773-11992853,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18318773-12076233,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18318773-12367677,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18318773-12510841,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18318773-14603504,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18318773-15464535,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18318773-15928675,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18318773-16023993,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18318773-16432090,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18318773-9066092
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1365-2125
|
pubmed:author |
pubmed-author:ChoJoo-YounJY,
pubmed-author:ChungJae-YongJY,
pubmed-author:JangIn-JinIJ,
pubmed-author:KimBo-HyungBH,
pubmed-author:KimJung-RyulJR,
pubmed-author:LimHyeong-SeokHS,
pubmed-author:LimKyoung SooKS,
pubmed-author:PaickJae-SeungJS,
pubmed-author:ShinSang-GooSG,
pubmed-author:SohnDong-RyulDR,
pubmed-author:YuKyung-SangKS
|
pubmed:issnType |
Electronic
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
848-54
|
pubmed:dateRevised |
2011-1-11
|
pubmed:meshHeading |
pubmed-meshheading:18318773-Administration, Oral,
pubmed-meshheading:18318773-Adult,
pubmed-meshheading:18318773-Area Under Curve,
pubmed-meshheading:18318773-Dose-Response Relationship, Drug,
pubmed-meshheading:18318773-Double-Blind Method,
pubmed-meshheading:18318773-Erectile Dysfunction,
pubmed-meshheading:18318773-Humans,
pubmed-meshheading:18318773-Korea,
pubmed-meshheading:18318773-Male,
pubmed-meshheading:18318773-Penile Erection,
pubmed-meshheading:18318773-Phosphodiesterase Inhibitors,
pubmed-meshheading:18318773-Pyrimidines,
pubmed-meshheading:18318773-Sulfonamides
|
pubmed:year |
2008
|
pubmed:articleTitle |
Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects.
|
pubmed:affiliation |
Departments of Pharmacology and Clinical Pharmacology, Seoul National University College of Medicine and Hospital, Seoul, Korea.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|